Template:BerkiGEM2007 WikiPlaying
From 2007.igem.org
(Difference between revisions)
Line 349: | Line 349: | ||
position:absolute; | position:absolute; | ||
left:15px; | left:15px; | ||
- | top: | + | top:565px; |
width:138px; | width:138px; | ||
height:22px; | height:22px; | ||
Line 357: | Line 357: | ||
position:absolute; | position:absolute; | ||
left:16px; | left:16px; | ||
- | top: | + | top:666px; |
width:136px; | width:136px; | ||
height:24px; | height:24px; | ||
Line 365: | Line 365: | ||
position:absolute; | position:absolute; | ||
left:17px; | left:17px; | ||
- | top: | + | top:768px; |
width:139px; | width:139px; | ||
height:22px; | height:22px; | ||
Line 373: | Line 373: | ||
position:absolute; | position:absolute; | ||
left:16px; | left:16px; | ||
- | top: | + | top:871px; |
width:138px; | width:138px; | ||
height:24px; | height:24px; | ||
Line 381: | Line 381: | ||
position:absolute; | position:absolute; | ||
left:16px; | left:16px; | ||
- | top: | + | top:973px; |
width:142px; | width:142px; | ||
height:27px; | height:27px; | ||
Line 458: | Line 458: | ||
position:absolute; | position:absolute; | ||
left:10px; | left:10px; | ||
- | top: | + | top:573px; |
width:163px; | width:163px; | ||
height:43px; | height:43px; | ||
Line 466: | Line 466: | ||
position:absolute; | position:absolute; | ||
left:10px; | left:10px; | ||
- | top: | + | top:676px; |
width:164px; | width:164px; | ||
height:41px; | height:41px; | ||
Line 474: | Line 474: | ||
position:absolute; | position:absolute; | ||
left:19px; | left:19px; | ||
- | top: | + | top:777px; |
width:155px; | width:155px; | ||
height:41px; | height:41px; | ||
Line 482: | Line 482: | ||
position:absolute; | position:absolute; | ||
left:10px; | left:10px; | ||
- | top: | + | top:881px; |
width:163px; | width:163px; | ||
height:40px; | height:40px; | ||
Line 490: | Line 490: | ||
position:absolute; | position:absolute; | ||
left:19px; | left:19px; | ||
- | top: | + | top:982px; |
width:155px; | width:155px; | ||
height:42px; | height:42px; | ||
Line 503: | Line 503: | ||
<div id="apDiv6"> | <div id="apDiv6"> | ||
<div align="center"> <span class="style2"><strong><a href="https://2007.igem.org/Berkeley_UC_OxygenTransport">Oxygen Transport</a></strong></span><br> | <div align="center"> <span class="style2"><strong><a href="https://2007.igem.org/Berkeley_UC_OxygenTransport">Oxygen Transport</a></strong></span><br> | ||
- | <a href="https://2007.igem.org/ | + | <a href="https://2007.igem.org/Berkeley_UC_Hemoglobin"><img name="HemoglobinButton" src="https://static.igem.org/mediawiki/2007/c/cf/HemoglobinButton.gif" width="100" height="100" alt=""></a><a href="https://2007.igem.org/Berkeley_UC_Chaperones"><img name="Heme" src="https://static.igem.org/mediawiki/2007/4/48/HemeButton.gif" width="100" height="100" alt=""></a><a href="https://2007.igem.org/Berkeley_UC_Chaperones"><img name="AHSPButton" src="https://static.igem.org/mediawiki/2007/b/b5/AHSPButton.gif" width="100" height="100" alt=""></a><br> |
</div> | </div> | ||
</div> | </div> | ||
<div id="apDiv11"> | <div id="apDiv11"> | ||
- | <div align="center"><strong><span class="style2"><a href="https://2007.igem.org/ | + | <div align="center"><strong><span class="style2"><a href="https://2007.igem.org/Berkeley_UC_Chassis">Immunity</a> </span><br> |
<br> | <br> | ||
- | </strong><a href="https://2007.igem.org/ | + | </strong><a href="https://2007.igem.org/Berkeley_UC_msbB"><img name="ImmunityButton" src="https://static.igem.org/mediawiki/2007/f/f9/ImmunityButton.gif" width="175" height="125" alt=""></a></div> |
</div> | </div> | ||
<div id="apDiv13"> | <div id="apDiv13"> | ||
Line 525: | Line 525: | ||
</div> | </div> | ||
<div id="apDiv20"> | <div id="apDiv20"> | ||
- | <div align="center"><span class="style5"><a href="https://2007.igem.org/ | + | <div align="center"><span class="style5"><a href="https://2007.igem.org/Berkeley_UC_Deletions">Growth Control</a></span><a href="https://2007.igem.org/Berkeley_UC_Deletions"><img name="GrowthControlButton" src="https://static.igem.org/mediawiki/2007/b/bf/DNADeletionButton.gif" width="100" height="100" alt=""></a></div> |
</div> | </div> | ||
- | <div id="apDiv29"><a href="https://2007.igem.org/Berkeley_UC_OxygenTransport"><img name="OxygenTransportMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> | + | <div id="apDiv29"><a href="https://2007.igem.org/Berkeley_UC_OxygenTransport" target="https://2007.igem.org/Berkeley_UC_Hemoglobin"><img name="OxygenTransportMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> |
- | <div id="apDiv30"><a href="https://2007.igem.org/Berkeley_UC_Antioxidants"><img name="AntioxidantsMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> | + | <div id="apDiv30"><a href="https://2007.igem.org/Berkeley_UC_Antioxidants" target="https://2007.igem.org/Berkeley_UC_Chassis"><img name="AntioxidantsMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> |
- | <div id="apDiv31"><a href="https://2007.igem.org/Berkeley_UC_Immunity"><img name="ImmunityMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> | + | <div id="apDiv31"><a href="https://2007.igem.org/Berkeley_UC_Immunity" target="https://2007.igem.org/Berkeley_UC_Antioxidants"><img name="ImmunityMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> |
- | <div id="apDiv32"><a href="https://2007.igem.org/Berkeley_UC_GrowthControl"><img name="GrowthControlMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> | + | <div id="apDiv32"><a href="https://2007.igem.org/Berkeley_UC_GrowthControl" target="https://2007.igem.org/Berkeley_UC_Deletions"><img name="GrowthControlMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> |
- | <div id="apDiv33"><a href="https://2007.igem.org/Berkeley_UC_SystemController"><img name="ControllerMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> | + | <div id="apDiv33"><a href="https://2007.igem.org/Berkeley_UC_SystemController" target="https://2007.igem.org/Berkeley_UC_SystemController"><img name="ControllerMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> |
- | <div id="apDiv34"><a href="https://2007.igem.org/Berkeley_UC_Storage"><img name="StorageMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> | + | <div id="apDiv34"><a href="https://2007.igem.org/Berkeley_UC_Storage" target="https://2007.igem.org/Berkeley_UC_Storage"><img name="StorageMenu" src="https://static.igem.org/mediawiki/2007/4/44/LargeBlankMenuButton.jpg" width="155" height="40" alt=""></a></div> |
<div id="apDiv36"> | <div id="apDiv36"> | ||
- | <div align="center"><span class="style5"><a href="https://2007.igem.org/ | + | <div align="center"><span class="style5"><a href="https://2007.igem.org/Berkeley_UC_Hemoglobin">Begin Project Tour</a></span><a href="https://2007.igem.org/Berkeley_UC_Hemoglobin"><img name="UCForwardButton" src="https://static.igem.org/mediawiki/2007/a/a0/F-Blue.gif" width="65" height="50" alt=""></a></div> |
</div> | </div> | ||
Line 636: | Line 636: | ||
--> | --> | ||
- | <div id="apDiv40">Best viewed in the most recent version of firefox, because IE sucks. </div> | + | <div id="apDiv40">Best viewed in the <a href="http://www.mozilla.com/en-US/firefox/">most recent version of firefox</a>, because IE sucks. </div> |
<div id="apDiv41"><span class="style2"><strong>The global demand and importance</strong> for cheap, available, and disease free blood substitutes is undisputed. There are currently no red blood cell substitutes approved for clinical use in the US or the UK, and whole blood is almost always in short supply. Underdeveloped countries that need blood the most simply don’t have the infrastructure to support donation and storage, in addition a sizeable fraction of the population are disease carriers. We are developing an innovative and cheap blood substitute based on engineered <em>E. coli</em> with all the critical properties of human erythrocytes. These include the ability to safely exist in the bloodstream, carry oxygen, and be stored for prolonged periods in a freeze-dried state.</span></div> | <div id="apDiv41"><span class="style2"><strong>The global demand and importance</strong> for cheap, available, and disease free blood substitutes is undisputed. There are currently no red blood cell substitutes approved for clinical use in the US or the UK, and whole blood is almost always in short supply. Underdeveloped countries that need blood the most simply don’t have the infrastructure to support donation and storage, in addition a sizeable fraction of the population are disease carriers. We are developing an innovative and cheap blood substitute based on engineered <em>E. coli</em> with all the critical properties of human erythrocytes. These include the ability to safely exist in the bloodstream, carry oxygen, and be stored for prolonged periods in a freeze-dried state.</span></div> | ||
<div id="apDiv42"> | <div id="apDiv42"> | ||
- | <div align="center">Oxygen Transport</div> | + | <div align="center"><a href="https://2007.igem.org/Berkeley_UC_Hemoglobin">Oxygen Transport</a></div> |
</div> | </div> | ||
<div id="apDiv43"> | <div id="apDiv43"> | ||
- | <div align="center">Immunity</div> | + | <div align="center"><a href="https://2007.igem.org/Berkeley_UC_Chassis">Immunity</a></div> |
</div> | </div> | ||
<div id="apDiv44"> | <div id="apDiv44"> | ||
- | <div align="center">Antioxidants</div> | + | <div align="center"><a href="https://2007.igem.org/Berkeley_UC_Antioxidants">Antioxidants</a></div> |
</div> | </div> | ||
<div id="apDiv45"> | <div id="apDiv45"> | ||
- | <div align="center">Growth Control</div> | + | <div align="center"><a href="https://2007.igem.org/Berkeley_UC_Deletions">Growth Control</a></div> |
</div> | </div> | ||
<div id="apDiv46"> | <div id="apDiv46"> | ||
- | <div align="center">System Controller</div> | + | <div align="center"><a href="https://2007.igem.org/Berkeley_UC_SystemController">System Controller</a></div> |
</div> | </div> | ||
<div id="apDiv47"> | <div id="apDiv47"> | ||
- | <div align="center">Storage</div> | + | <div align="center"><a href="https://2007.igem.org/Berkeley_UC_Storage">Storage</a></div> |
</div> | </div> | ||
</body> | </body> |
Revision as of 08:42, 7 October 2007
Best viewed in the most recent version of firefox, because IE sucks.
The global demand and importance for cheap, available, and disease free blood substitutes is undisputed. There are currently no red blood cell substitutes approved for clinical use in the US or the UK, and whole blood is almost always in short supply. Underdeveloped countries that need blood the most simply don’t have the infrastructure to support donation and storage, in addition a sizeable fraction of the population are disease carriers. We are developing an innovative and cheap blood substitute based on engineered E. coli with all the critical properties of human erythrocytes. These include the ability to safely exist in the bloodstream, carry oxygen, and be stored for prolonged periods in a freeze-dried state.